EZETIMIB ROSUVAST axapharm cpr pell 10/10mg 90 pce

7680690040024 CH-69004 C10BA06 07.12.0.

Reimbursement limitations:

EZET_ROS_AXA

EZETIMIB ROSUVASTATIN AXAPHARM est indiqué comme traitement substitutif chez le patient adulte qui reçoit déjà …

EZETIMIB ROSUVAST axapharm cpr pell 10/10mg 90 pce
EZETIMIB ROSUVAST axapharm cpr pell 10/10mg 90 pce
EZETIMIB ROSUVAST axapharm cpr pell 10/10mg 90 pce
1 / 3
google

Details

Product number
6900401
CPT
-
Packaging group
90
Unit
Tablette(n)
Composition
rosuvastatinum 10 mg ut rosuvastatinum calcicum 10.4 mg, ezetimibum 10 mg, lactosum monohydricum 200.5 mg, carmellosum natricum conexum, povidonum K 30, natrii laurilsulfas, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 172 (flavum), titanii dioxidum, macrogolum 4000, talcum, pro compresso obducto corresp. natrium 3.02 mg.

Articles (1)

Ezetimib Rosuvastatin axapharm 10 mg/10 mg, Filmtabletten
Filmtabletten
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
02/09/2025
Professional SmPC
Français
02/09/2025
Professional SmPC
Italien
02/09/2025
Patient information leaflet
Allemand
31/10/2024
Patient information leaflet
Français
31/10/2024
Patient information leaflet
Italien
31/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.4 MG Substance WIZUS
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
200.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.02 MG Substance HBESI

Reimbursement information

Public price
CHF 71.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2024

Authorization holder

axapharm ag

6340 Baar

Authorization information

Swissmedic authorization number
69004
Drug name
Ezetimib Rosuvastatin axapharm, Filmtabletten
Galenic form
FILM
ATC Code
C10BA06
Authorization status
Z
Dispensation category
B
First authorization
19/07/2023
Authorization expiration date
18/07/2028
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
EZETIMIB ROSUVAST axapharm cpr pell 10/10mg 90 pce
Description (DE)
EZETIMIB ROSUVAST axapharm Filmtabl 10/10mg 90 Stk
Market launch
19/07/2023
Narcotic (BTM)
No

Other packaging sizes

EZETIMIB ROSUVAST axapharm cpr pell 10/10mg 30 pce
30 TABL
View
EZETIMIB ROSUVAST axapharm cpr pell 10/20mg 30 pce
30 TABL
View
EZETIMIB ROSUVAST axapharm cpr pell 10/20mg 90 pce
90 TABL
View